The table below shows the Nifty Healthcare Stocks List by highest market cap.
| Name | Market Cap ( Cr ) | Close Price |
| Sun Pharmaceutical Industries Ltd | 374596.17 | 1561.25 |
| Cipla Ltd | 118392.06 | 1466.40 |
| Dr Reddy’s Laboratories Ltd | 107270.41 | 6442.15 |
| Apollo Hospitals Enterprise Ltd | 97400.45 | 6774.05 |
| Divi’s Laboratories Ltd | 96845.59 | 3648.10 |
| Zydus Lifesciences Ltd | 93451.75 | 923.25 |
| Torrent Pharmaceuticals Ltd | 88907.92 | 2626.95 |
| Max Healthcare Institute Ltd | 82792.62 | 851.90 |
| Lupin Ltd | 73559.19 | 1614.95 |
| Alkem Laboratories Ltd | 64817.98 | 5421.15 |
Content:
- Nifty Healthcare Stocks Weightage
- Introduction to Nifty Healthcare Stocks List
- Nifty Healthcare – FAQ
Nifty Healthcare Stocks Weightage
The following table illustrates Top 10 Nifty Healthcare Stocks arranged by weightage in descending order.
| Name | Weightage ( % ) |
| Sun Pharmaceutical Industries Ltd | 23.09 |
| Dr Reddy’s Laboratories Ltd | 10.6 |
| Cipla Ltd | 10.53 |
| Apollo Hospitals Enterprise Ltd | 8.32 |
| Max Healthcare Institute Ltd | 7.94 |
| Divi’s Laboratories Ltd | 6.03 |
| Lupin Ltd | 5.3 |
| Aurobindo Pharma Ltd | 3.92 |
| Alkem Laboratories Ltd | 3.49 |
| Torrent Pharmaceuticals Ltd | 3.3 |
Stocks in Nifty Healthcare Index
Sun Pharmaceutical Industries Ltd
The market capitalization of Sun Pharmaceutical Industries Ltd stands at ₹374,596.17. Its one-month return percentage is 18.39, and its one-year return percentage is 60.54. The stock is currently 0.46% away from its 52-week high. Sun Pharmaceutical Industries Ltd holds a stock weightage of 23.09%.
Sun Pharmaceutical Industries Limited, headquartered in India, is a specialized generic pharmaceutical firm. The company’s operations encompass the manufacturing, research, and promotion of a broad array of branded and generic drugs and active pharmaceutical ingredients (APIs).
Sun Pharma offers an extensive and diverse portfolio of medications with a focus on chronic and acute therapies. Its integrated supply chain facilitates the production of various pharmaceuticals, spanning oncology, hormones, peptides, and steroidal drugs.
Dr Reddy’s Laboratories Ltd
The market capitalization of Dr. Reddy’s Laboratories Ltd is ₹107,270.41. Its one-month return percentage is 12.60, and its one-year return percentage is 44.78. The stock is currently 0.81% away from its 52-week high. Dr. Reddy’s Laboratories Ltd holds a stock weightage of 10.60%.
Dr. Reddy’s Laboratories Limited, headquartered in India, is a prominent global pharmaceutical entity. It offers a diverse range of products and services encompassing active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars, and over-the-counter (OTC) medications.
The company concentrates its efforts on various therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Dr. Reddy’s operates through distinct segments including Pharmaceutical Services and Active Ingredients, Global Generics, and Others.
Cipla Ltd
The market capitalization of Cipla Ltd is ₹118,392.06. Its one-month return percentage is 4.93, and its one-year return percentage is 52.70. The stock is currently 1.09% away from its 52-week high. Cipla Ltd holds a stock weightage of 10.53%.
Cipla Limited, an India-based pharmaceutical company, primarily focuses on pharmaceuticals and operates in two segments: Pharmaceuticals and New Ventures.
The Pharmaceuticals segment involves developing, manufacturing, selling, and distributing generic or branded generic medicines and Active Pharmaceutical Ingredients (API). The New Ventures segment encompasses consumer healthcare, Biosimilars, and specialty businesses.
Apollo Hospitals Enterprise Ltd
The market capitalization of Apollo Hospitals Enterprise Ltd stands at ₹97,400.45. Its one-month return percentage is 6.27, and its one-year return percentage is 52.29. The stock is currently 1.48% away from its 52-week high. Apollo Hospitals Enterprise Ltd holds a stock weightage of 8.32%.
Apollo Hospitals Enterprise Limited, an integrated healthcare company based in India, operates a diverse range of services encompassing hospital care, pharmaceutical sales, and wellness products distribution.
Its operations span multidisciplinary private hospitals, clinics, diagnostic centers, and pharmacies. The company’s business segments include Healthcare Services, Retail Health and Diagnostics, Digital Health and Pharmacy Distribution, among others. With a focus on hospitals and related services, it offers a comprehensive suite of healthcare solutions.
Max Healthcare Institute Ltd
The market capitalization of Max Healthcare Institute Ltd is ₹82,792.62. Its one-month return percentage is 8.74, and its one-year return percentage is 98.93. The stock is currently 6.82% away from its 52-week high. Max Healthcare Institute Ltd holds a stock weightage of 7.94%.
Max Healthcare Institute Limited, headquartered in India, is a healthcare organization that operates within the Medical and Healthcare Services sector. It also manages a homecare division and a pathology division branded as Max@Home and Max Lab respectively.
Max@Home delivers health and wellness services directly to individuals’ residences, while Max Lab offers pathology services beyond the confines of its hospital network. The company specializes in various medical fields including cancer care/oncology, cardiac sciences, endocrinology, joint replacement, bariatric surgery/metabolic, robotic surgery, kidney transplant, bone marrow transplant, urology, and vascular surgery.
Divi’s Laboratories Ltd
The market capitalization of Divi’s Laboratories Ltd is ₹96,845.59. Its one-month return percentage is -0.54, and its one-year return percentage is 26.97. The stock is currently 11.69% away from its 52-week high. Divi’s Laboratories Ltd holds a stock weightage of 6.03%.
Divi’s Laboratories Limited, an India-based company, specializes in the manufacturing and sale of active pharmaceutical ingredients (APIs), intermediates, and nutraceutical ingredients primarily focused on exports.
Its product portfolio encompasses a variety of pharmaceutical substances such as Bupropion HCl, Capecitabine, Carbidopa, and others. Alongside its generic operations, the company offers custom synthesis services to support pharmaceutical firms in various stages from clinical trials to late-stage management of patented products.
Lupin Ltd
The market capitalization of Lupin Ltd stands at ₹73,559.19. Its one-month return percentage is 11.92, and its one-year return percentage is 145.30. The stock is currently 5.27% away from its 52-week high. Lupin Ltd holds a stock weightage of 5.3%.
Lupin Limited, an Indian pharmaceutical company, specializes in producing, developing, and global marketing a wide array of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs).
The company operates in various therapeutic segments such as Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives, Nonsteroidal Anti-Inflammatory Drugs, Anti-TB, and Cephalosporins.
Aurobindo Pharma Ltd
The market capitalization of Aurobindo Pharma Ltd is ₹61,160.27. Its one-month return percentage is -9.74, and its one-year return percentage is 123.22. The stock is currently 12.77% away from its 52-week high. Aurobindo Pharma Ltd holds a stock weightage of 3.92%.
Aurobindo Pharma Limited, headquartered in India, primarily produces and promotes active pharmaceutical ingredients, branded and generic pharmaceuticals, and associated services.
Its diverse product range spans seven therapeutic areas, including Central Nervous System (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP – Orals & Sterile, Anti-infectives, Anti-diabetics, and Cephalosporins – Orals. The company is actively involved in developing oncology and hormonal medications and topical and transdermal products within the dermatology sector.
Alkem Laboratories Ltd
The market capitalization of Alkem Laboratories Ltd is ₹64,817.98. Its one-month return percentage is 11.31, and its one-year return percentage is 65.51. The stock is currently 1.82% away from its 52-week high. Alkem Laboratories Ltd holds a stock weightage of 3.49%.
Alkem Laboratories Limited, headquartered in India, is a pharmaceutical company with a global presence. It specializes in researching, producing, and distributing pharmaceutical and nutraceutical products across various therapeutic areas.
These include Anti Infective, Dermatology, Diabetology, Cardiology, Gastroenterology, Osteoporosis, Rheumatology, central nervous system (CNS), Oncology, Urology, Gynecology, as well as Vitamins, Minerals, and Nutrition.
Torrent Pharmaceuticals Ltd
The market capitalization of Torrent Pharmaceuticals Ltd stands at ₹88,907.92. Its one-month return percentage is 2.68, and its one-year return percentage is 77.32. The stock is currently 2.78% away from its 52-week high. Torrent Pharmaceuticals Ltd holds a stock weightage of 3.3%.
Torrent Pharmaceuticals Limited, an Indian-based pharmaceutical company, concentrates on diverse therapeutic segments such as cardiovascular (CV), central nervous system (CNS), gastrointestinal (GI), vitamins, minerals nutrients (VMN), anti-diabetes (AD), pain, gynecology, and dermatology.
The company is actively involved in the research, development, manufacturing, marketing, and global distribution of branded and generic pharmaceutical formulations.
Nifty Healthcare – FAQ
How many stocks are there in the Nifty Healthcare Index?
The Nifty Healthcare Index consists of a maximum of 20 tradable companies that are listed on exchanges. It is calculated using the free float market capitalization method, where the index level represents the overall free float market value of all the stocks in the index about a specific base market capitalization value.
How to invest in Nifty Healthcare?
Investing in Nifty Healthcare involves purchasing shares of the companies within the index through a stockbroker. Utilize a trading account to buy and sell stocks based on market analysis.
What is the largest Healthcare stock?
Sun Pharmaceutical Industries Ltd, Cipla Ltd, and Dr. Reddy’s Laboratories Ltd are the three leading healthcare stocks, determined by their respective market capitalizations.
What is the symbol of the Nifty Healthcare Index?
The Nifty Healthcare Index’s symbol on the National Stock Exchange of India (NSE) is “NIFTYHEALTH.”
Is it good to invest in Nifty healthcare stocks?
Investing in Nifty healthcare stocks can be a strategic move, as the sector often demonstrates resilience and growth potential. However, like any investment, it carries risks, including market fluctuations and industry-specific challenges.
What is the difference between Nifty Pharma and Nifty Healthcare?
Nifty Pharma and Nifty Healthcare are both indices on the National Stock Exchange (NSE) of India. Nifty Pharma specifically focuses on pharmaceutical companies, while Nifty Healthcare encompasses a broader range, including pharmaceuticals, hospitals, and healthcare services.
We hope you’re clear on the topic, but there’s more to explore in stocks, commodities, mutual funds, and related areas. Here are important topics to learn about.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.
